Effects of blocking CD24 and CD47 ‘don't eat me’ signals in combination with rituximab in mantle‐cell lymphoma and chronic lymphocytic leukaemia

Mantle‐cell lymphoma (MCL) is a B‐cell non‐Hodgkin Lymphoma (NHL) with a poor prognosis, at high risk of relapse after conventional treatment. MCL‐associated tumour microenvironment (TME) is characterized by M2‐like tumour‐associated macrophages (TAMs), able to interact with cancer cells, providing...

Descripción completa

Detalles Bibliográficos
Autores principales: Aroldi, Andrea, Mauri, Mario, Ramazzotti, Daniele, Villa, Matteo, Malighetti, Federica, Crippa, Valentina, Cocito, Federica, Borella, Chiara, Bossi, Elisa, Steidl, Carolina, Scollo, Chiara, Voena, Claudia, Chiarle, Roberto, Mologni, Luca, Piazza, Rocco, Gambacorti‐Passerini, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568669/
https://www.ncbi.nlm.nih.gov/pubmed/37654003
http://dx.doi.org/10.1111/jcmm.17868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568669/
https://www.ncbi.nlm.nih.gov/pubmed/37654003
http://dx.doi.org/10.1111/jcmm.17868

Ejemplares similares